Bone cancer pain

Bone cancer pain

Blog Article

In 2012, the International Agency for Research on Cancer reported 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.

6 million people living with cancer.Cancer pain not only causes significant suffering but also contributes to a decreased quality of life, functional status, and greatly increases health-care costs.The bones are a common site for metastases, especially tumors involving x515ea-bh55-cb breast, lung, prostate, and kidneys.

This can lead to significant pain, pathological fractures, compression of the spinal cord, poor quality of life, and increased mortality.Pathophysiology of cancer-induced bone pain is complex and has neuropathic and nociceptive characteristics.The aim of the treatment of bone metastases is palliating painful symptoms and preventing progression mushroom wall decal of skeletal-related events.

A multimodal approach including various cancer therapies, analgesic and adjuvant agents, and interventional modalities should be used.This review focuses on the pathophysiology of bone cancer pain and pharmacological and non-pharmacological modalities that reduce bone cancer pain.